Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: Reappraisal of the staging system for solitary tumors

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1223-1229

  Shindoh, Junichi ^a   Andreou, Andreas ^a   Aloia, Thomas A ^a   Zimmitti, Giuseppe ^a   Lauwers, Gregory Y ^b   Laurent, Alexis ^c   Nagorney, David M ^d   Belghiti, Jacques ^e   Cherqui, Daniel ^c   Poon, Ronnie Tung Ping ^f   Kokudo, Norihiro ^g   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HENRI MONDOR HOSPITAL   (France)

^d MAYO CLINIC   (United States)

^e BEAUJON HOSPITAL   (France)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADOLESCENT; ADULT; AGED; CANCER INVASION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONFERENCE PAPER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR INVASION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84875216471     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2739-y     Document Type: Conference Paper

References (33)

1. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
2. CH Cheng CF Lee TH Wu KM Chan HS Chou TJ Wu, et al. 2011 Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma World J Surg Oncol. 9 114 21958080 10.1186/1477-7819-9-114
3. KM Kee JH Wang CM Lee CL Chen CS Changchien TH Hu, et al. 2007 Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan Int J Cancer. 120 2650 2655 17304512 10.1002/ijc.22616 1:CAS:528:DC%2BD2sXkslGiuro%3D
4. HJ Lei GY Chau WY Lui SH Tsay KL King CC Loong, et al. 2006 Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma J Am Coll Surg. 203 426 435 17000385 10.1016/j.jamcollsurg.2006.06.030
5. Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am. 2003;12:35-50, viii.
6. G Ramacciato P Mercantini N Cautero N Corigliano F Di Benedetto C Quintini, et al. 2005 Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma Ann Surg Oncol. 12 289 297 15827681 10.1245/ASO.2005.03.098
7. G Varotti G Ramacciato G Ercolani GL Grazi G Vetrone M Cescon, et al. 2005 Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients Eur J Surg Oncol. 31 760 767 15975760 10.1016/j.ejso.2005.04.008 1:STN:280:DC%2BD2MvlvVCgsw%3D%3D
8. CC Wu SB Cheng WM Ho JT Chen TJ Liu FK P'Eng 2005 Liver resection for hepatocellular carcinoma in patients with cirrhosis Br J Surg. 92 348 355 15672423 10.1002/bjs.4838
9. T Takayama M Makuuchi S Hirohashi M Sakamoto J Yamamoto K Shimada, et al. 1998 Early hepatocellular carcinoma as an entity with a high rate of surgical cure Hepatology. 28 1241 1246 9794907 10.1002/hep.510280511 1:STN:280: DyaK1M%2FhtlyqsQ%3D%3D
10. Yamashita YI, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, et al. Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol. 2012;19:2027-34.
11. K Inoue T Takayama T Higaki Y Watanabe M Makuuchi 2004 Clinical significance of early hepatocellular carcinoma Liver Transplant. 10 S16 S19 10.1002/lt.20049
12. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004;240:451-9; discussion 59-61.
13. T Livraghi F Meloni M Di Stasi E Rolle L Solbiati C Tinelli, et al. 2008 Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 47 82 89 18008357 10.1002/hep.21933
14. S Arii Y Yamaoka S Futagawa K Inoue K Kobayashi M Kojiro, et al. 2000 Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology. 32 1224 1229 11093728 10.1053/jhep.2000.20456 1:STN:280:DC%2BD3M%2FntFegsQ%3D%3D
15. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 5th ed. Tokyo: Kanehara; 2008.
16. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet. 362 1907 1917 14667750 10.1016/S0140-6736(03)14964-1
17. Liver Cancer Study Group of Japan 1990 Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan Ann Surg. 211 277 287
18. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med. 334 693 699 8594428 10.1056/NEJM199603143341104 1:STN:280:DyaK287nsFWltw%3D%3D
19. M Makuuchi J Belghiti G Belli ST Fan JW Lau B Ringe, et al. 2003 IHPBA concordant classification of primary liver cancer: working group report J Hepatobiliary Pancreatic Surg. 10 26 30
20. S Jonas WO Bechstein T Steinmuller M Herrmann C Radke T Berg, et al. 2001 Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology. 33 1080 1086 11343235 10.1053/jhep.2001.23561 1:STN:280:DC%2BD3MzgvFOluw%3D%3D
21. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer. 7 462 503 13160935 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E 1:STN:280:DyaG2c%2FotV2mtQ%3D%3D
22. K Ishak A Baptista L Bianchi F Callea J De Groote F Gudat, et al. 1995 Histological grading and staging of chronic hepatitis J Hepatol. 22 696 699 7560864 10.1016/0168-8278(95)80226-6 1:STN:280:DyaK28%2FjsFWntw%3D%3D
23. NN Rahbari A Mehrabi NM Mollberg SA Muller M Koch MW Buchler, et al. 2011 Hepatocellular carcinoma: current management and perspectives for the future Ann Surg. 253 453 469 21263310 10.1097/SLA.0b013e31820d944f
24. The Cancer of the Liver Italian Program (CLIP) Investigators 1998 A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) Investigators Hepatology. 28 751 755 10.1002/hep.510280322
25. JM Llovet C Bru J Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis. 19 329 338 10518312 10.1055/s-2007-1007122 1:STN:280:DyaK1Mvks1Grsg%3D%3D
26. JN Vauthey GY Lauwers NF Esnaola KA Do J Belghiti N Mirza, et al. 2002 Simplified staging for hepatocellular carcinoma J Clin Oncol. 20 1527 1536 11896101 10.1200/JCO.20.6.1527
27. Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, et al. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg. 2007;204(5):1016-27.
28. T Kanai S Hirohashi MP Upton M Noguchi K Kishi M Makuuchi, et al. 1987 Pathology of small hepatocellular carcinoma. A proposal for a new gross classification Cancer. 60 810 819 2439190 10.1002/1097-0142(19870815)60: 4<810::AID-CNCR2820600417>3.0.CO;2-1 1:STN:280:DyaL2s3ktl2msw%3D%3D
29. H Tsuda WD Zhang Y Shimosato J Yokota M Terada T Sugimura, et al. 1990 Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma Proc Natl Acad Sci USA 87 6791 6794 2168560 10.1073/pnas.87.17.6791 1:CAS:528:DyaK3cXls12lt7s%3D
30. M Kojiro H Yano O Nakashima 1996 Pathology of early hepatocellular carcinoma: progression from early to advanced Semin Surg Oncol. 12 197 203 8727611 10.1002/(SICI)1098-2388(199605/06)12:3<197::AID-SSU10>3.0.CO;2-V 1:STN:280:DyaK28zisVShtQ%3D%3D
31. Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, et al. Resection of hepatocellular cancer ≤ 2 cm: results from two western centers. Hepatology. 2012. (accepted).
32. M Sala J Fuster JM Llovet M Navasa M Sole M Varela, et al. 2004 High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation Liver Transplant. 10 1294 1300 10.1002/lt.20202
33. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238:885-92; discussion 92-3.